Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Stephen, J. Macduffie-Woodburne, E. KiaRash, R. Rahim, M. Rossman (Philadlephia, Philadelphia, United States Of America). 3he MRI and an animal model of interstitial lung disease. Eur Respir J 2009; 34: Suppl. 53, 163

Member's Comments

No comment yet.

Related content which might interest you: MRI and CT imaging of in vivo models of drug-induced interstitial lung diseases. Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease Year: 2018 Biological- and imaging biomarkers of edema and fibrosis in a rat model of drug-induced interstitial lung disease (DIILD) Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 CT and interstitial lung disease Source: International Congress 2018 – PG4 Imaging of the chest Year: 2018 Molecular imaging of the progression of pulmonary fibrosis using animal models of disease Source: Eur Respir J 2006; 28: Suppl. 50, 605s Year: 2006 Oxygen enhanced MRI biomarkers of lung function in interstitial lung disease Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease Year: 2020 MRI metric lung parenchyma T1 indicates lung pathology in patients with pulmonary hypertension. Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021 Use of MRI for functional and structural assessment of interstitial lung disease Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease Year: 2018 Computed-tomography-based radiomics features for staging of interstitial lung disease – transferability from experimental to human lung fibrosis - a proof-of-concept study Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update Year: 2019 Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Use of PET/CT to evaluate pulmonary inflammation and fibrosis in an animal model Source: Eur Respir J 2006; 28: Suppl. 50, 606s Year: 2006 In vivo monitoring of cystic fibrosis-like lung disease in mice by volumetric computed tomography Source: Eur Respir J 2011; 38: 1060-1070 Year: 2011 A comparison of MRI findings in cases with progressive massive fibrosis and lung cancer Source: Virtual Congress 2020 – Screening and imaging in lung cancer Year: 2020 Preclinical models and imaging biomarkers of lung injury and disease Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease Year: 2021 Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Using the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2015 – IIPs: orphan Year: 2015 A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Pertechnegas lung clearance in different forms of interstitial lung disease Source: Eur Respir J 2002; 19: 31-36 Year: 2002